presented Archives - AudioMedica.com

Tagged: presented

0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH:
Oblimersen Extends Survival in Chronic Lymphocytic Leukemia

Susan O’Brien
SUSAN O’BRIEN, MD Anderson Cancer Center, Houston
For patients with relapsed or refractory CLL, oblimersen extends survival when added to standard fludarabine/cyclophosphamide chemotherapy. Susan O’Brien presented data from this phase III trial to the American Society of Hematology
…
Read more
0
- in Oncology
- — 10 Dec, 2007
Live Report from ASH: Azacitidine ‘New Standard’ In High Risk Myelodysplastic Syndromes

Pierre Fenaux
PIERRE FENAUX, Paris 13 University
Results from a phase III study presented at ASH suggest that the hypomethylating agent azacitidine should be the new standard of care for patients with high-risk MDS. Pierre Fenaux of Paris 13 University
…
Read more
0
- in Cardiovascular
- — 5 Nov, 2007
Long Term Outcomes of Drug Eluting and Bare Metal Stents in Patients Undergoing PCI

Laura Mauri

Raymond Gibbons
REFERENCE: Late Breaking Special Session, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LAURA MAURI, Brigham and Woman’s Hospital, Boston Massachusetts
COMMENT: RAYMOND GIBBONS, Mayo Clinic, Rochester, Minnesota
The largest study to date looking
…
Read more
0
- in Cardiovascular
- — 5 Nov, 2007
Stable Angina: Add PCI To Medical Therapy If Guided by SPECT-Detected Ischemia? COURAGE Nuclear Sub-Study Results
REFERENCE: Abstract: Late Breaking Clinical Trials, Session 1, American Heart Association Scientific Sessions, 4-7 November, 2007, Orlando, Florida
LESLEE SHAW, Emory University, Atlanta
COMMENT: DANIEL JONES, AHA President, University of Mississippi, Jackson
Some patients with stable angina may be best …
Read more
0
- in Oncology
- — 16 Oct, 2007
Neoadjuvant Trastuzumab: Marked Benefit in HER2-Positive Inflammatory Breast Cancer

Jose Baselga

Gordon McVie
REFERENCE: ABSTRACT 2030, ECCO 14, The European Cancer Conference, Barcelona, 23 – 27 September 2007
JOSE BASELGA, Vall d’Hebron University Hospital, Barcelona
COMMENT: GORDON MCVIE, European Institute of Oncology, Milan
Neoadjuvant trastuzumab for patients with HER2-positive
…
Read more
0
- in Public Health
- — 19 Sep, 2007
Vancomycin: New Guidelines May Induce Kidney Damage

Megan Nguyen
REFERENCE: Poster Session 104 K-1096, 47th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, 2007
MEGAN NGUYEN, Western University in Pomona, California
New vancomycin guidelines that recommend using higher doses may cause kidney damage according to
…
Read more
0
- in Oncology
- — 15 Aug, 2007
Virus Plus Cytokine Fight Primary and Metastatic Cancer

Paul Fisher
REFERENCE: Meet the Professor Session, AACR 2007, Los Angeles
PAUL FISHER, Columbia University, New York
Patients with cancer could soon be treated with adenoviruses capable of infecting both primary and distant tumors, and simultaneously releasing cancer-fighting cytokines, according
…
Read more
0
- in ICAAC 2005
- — 7 Jan, 2006
Fire Ants: Purveyors of Pain, or Possible Source of New Antimicrobials?

Heather White
Heather White, University of Mississippi Medical Center, Jackson
If you have ever been bitten by a fire ant you’ll remember the pain! But a study presented in Washington has shown that when they sting, they produce substances with …
Read more

Tagged: presented

Sign up for AudioMedica.com news